Quantum BioPharma Stock Forecast - Accumulation Distribution

QNTM Stock   7.30  0.03  0.41%   
Quantum Stock Forecast is based on your current time horizon. Although Quantum BioPharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Quantum BioPharma's systematic risk associated with finding meaningful patterns of Quantum BioPharma fundamentals over time.
As of now the rsi of Quantum BioPharma's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Quantum BioPharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Quantum BioPharma and does not consider all of the tangible or intangible factors available from Quantum BioPharma's fundamental data. We analyze noise-free headlines and recent hype associated with Quantum BioPharma, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Quantum BioPharma's stock price prediction:
EPS Estimate Next Quarter
(3.44)
EPS Estimate Current Year
(11.36)
EPS Estimate Next Year
(5.16)
Wall Street Target Price
44.917
EPS Estimate Current Quarter
(3.70)
Using Quantum BioPharma hype-based prediction, you can estimate the value of Quantum BioPharma from the perspective of Quantum BioPharma response to recently generated media hype and the effects of current headlines on its competitors.

Quantum BioPharma Hype to Price Pattern

Investor biases related to Quantum BioPharma's public news can be used to forecast risks associated with an investment in Quantum. The trend in average sentiment can be used to explain how an investor holding Quantum can time the market purely based on public headlines and social activities around Quantum BioPharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Quantum BioPharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Quantum BioPharma.

Quantum BioPharma after-hype prediction price

    
  USD 7.3  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.As of the 2nd of January 2026, Inventory Turnover is likely to drop to 2.30. In addition to that, Payables Turnover is likely to drop to 0.49. As of the 2nd of January 2026, Common Stock Shares Outstanding is likely to grow to about 1.4 M.

Quantum BioPharma Additional Predictive Modules

Most predictive techniques to examine Quantum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quantum using various technical indicators. When you analyze Quantum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Quantum BioPharma has current Accumulation Distribution of 0.12. The accumulation distribution (A/D) indicator shows the degree to which Quantum BioPharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Quantum BioPharma to determine if accumulation or reduction is taking place in the market. This value is adjusted by Quantum BioPharma trading volume to give more weight to distributions with higher volume over lower volume.
Check Quantum BioPharma VolatilityBacktest Quantum BioPharmaInformation Ratio  

Quantum BioPharma Trading Date Momentum

On January 02 2026 Quantum BioPharma was traded for  7.30  at the closing time. The top price for the day was 7.88  and the lowest listed price was  6.90 . There was no trading activity during the period 0.0. Lack of trading volume on January 2, 2026 did not cause price change. The trading delta at closing time against the current closing price is 4.11% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Quantum BioPharma to competition

Other Forecasting Options for Quantum BioPharma

For every potential investor in Quantum, whether a beginner or expert, Quantum BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Quantum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Quantum. Basic forecasting techniques help filter out the noise by identifying Quantum BioPharma's price trends.

Quantum BioPharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quantum BioPharma stock to make a market-neutral strategy. Peer analysis of Quantum BioPharma could also be used in its relative valuation, which is a method of valuing Quantum BioPharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Quantum BioPharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Quantum BioPharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Quantum BioPharma's current price.

Quantum BioPharma Market Strength Events

Market strength indicators help investors to evaluate how Quantum BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quantum BioPharma shares will generate the highest return on investment. By undertsting and applying Quantum BioPharma stock market strength indicators, traders can identify Quantum BioPharma entry and exit signals to maximize returns.

Quantum BioPharma Risk Indicators

The analysis of Quantum BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Quantum BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting quantum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Quantum BioPharma is a strong investment it is important to analyze Quantum BioPharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Quantum BioPharma's future performance. For an informed investment choice regarding Quantum Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.
You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.55)
Return On Assets
(0.72)
Return On Equity
(2.51)
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.